Expanding to Australia, PYFA wraps up Probiotec acquisition
20 Jun 2024 09:48
PT Pyridam Farma Tbk’s (PYFA) steps in expanding the market to Australia is now materialised after acquiring the entire shares of Probiotic Limited, Australia.
Eyeing 7% growth, DVLA prepares capex of IDR 209 billion
11 Jun 2024 17:31
PT Darya-Varia Laboratoria Tbk (DVLA) is reportedly preparing capital expenditure (capex) budget worth IDR 209 billion for 2024, which will mostly be allocated for expansion.
Distributing another IDR 65, Darya-Varia’s dividend clocks up to IDR 108 per share
11 Jun 2024 16:00
PT Darya-Varia Laboratoria Tbk (DVLA) sets up IDR 65 per share for the final dividend of the fiscal year (FY) 2023, totalling IDR 72.8 billion, which will be taken out of its current year’s net profit in 2023.
Seeing 130.96% downturn, PYFA lost IDR 85.22 billion
15 Mar 2024 09:55
The performance of PT Pyridam Farma Tbk (PYFA) declined throughout 2023 compared to 2022.